<DOC>
	<DOCNO>NCT00778024</DOCNO>
	<brief_summary>The objective study compare relative bioavailability fluoxetine HCL 40 mg capsule ( Ranbaxy Laboratories Limited ) PROZAC® 40 mg capsule ( Dista Products Company ) follow single oral dose ( 1 x 40 mg capsule ) healthy , adult subject fast condition</brief_summary>
	<brief_title>Bioequivalence Study Fluoxetine HCL 40 mg Capsules Under Fasting Conditions</brief_title>
	<detailed_description>This single-dose , open-label , randomized two-way crossover study evaluate bioequivalence test formulation , versus equivalent dose commercially available reference drug product , 36 adult subject , fast condition . Drug administration separate least 49 day . Vital sign ( sit blood pressure pulse rate ) obtain baseline ( Hour 0 ) , post-dose Hours 3 , 8 , 12 , 24 , 48 , 72 , 360 , 1056 . Of 36 subject enrol study , 31 subject complete study entirety . Five ( 5 ) subject drop study .</detailed_description>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>1 . Sex : Male Female ; similar proportion prefer . 2 . Age : At least 18 year . 3 . Qualifying subject must good health physical condition determine medical history , complete physical examination , laboratory test , obtain within four ( 4 ) week prior study start . The subject may history significant past illness expect affect investigation . The normal status subject confirm follow procedure : • Laboratory Tests : Hemoglobin , hematocrit , RBC , WBC , differential count , serum electrolyte ( Na , K , CL ) , fast blood glucose , BUN , bilirubin , creatinine , AST , ALT , LD , alkaline phosphatase , urinalysis . HIV , Hepatitis B , Hepatitis C , drug abuse test do screening purpose . Urine drug abuse test repeat checkin . Female subject serum pregnancy test do screen urine pregnancy test prior study period checkin . Laboratory value great : E20 % normal range qualify unless specifically accept ( comment ) Principal Investigator . Results HIV , Hepatitis B , Hepatitis C , drug abuse must negative nonreactive subject qualify study . • Electrocardiogram : A 12lead electrocardiogram ( ECG ) obtain subject . The original tracing , plus interpretation , include case report form packet . 4 . Subjects must read sign Consent Form . 1 . Subjects comply inclusion criterion must exclude study . 2 . In addition , one condition list exclude subject study : History treatment alcoholism , substance abuse , drug abuse within past 24 month . History malignancy , stroke , diabetes , cardiac , renal liver disease , serious illness . History GERD ( gastroesophageal reflux disease ) , malabsorption syndrome , colon cancer , chronic colitis , include Crohn 's disease . History treatment astlzurta within past five ( 5 ) year . History neurological impairment . History seizure . History Parkinson 's Disease . History diabetes mellitus . Females pregnant lactating . History hypersensitivity fluoxetine HCL , serotonin reuptake inhibitor . 3 . Conditions upon screen might contraindicate require caution use administration fluoxetlne HCL , include : Sitting systolic blood pressure 90 mm Hg , diastolic Pressure 50 mm Hg . Heart rate le 50 beat per minute 5minute rest 4 . Inability read and/or sign consent form . 5 . Treatment investigational drug four ( 4 ) week prior initial dose study . 6 . Subjects donate blood within four ( 4 ) week prior Initial dose study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Bioequivalence fluoxetine HCL 40 mg capsule fast condition</keyword>
</DOC>